BLCO Bausch + Lomb Corp

  1. Stocks
  2. Healthcare
  3. NYSE: BLCO

Price (delayed)

$15.38

Market cap

$5.48B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.63

Enterprise value

$10.27B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 51

Bausch + Lomb is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world—from the moment of birth ...

Highlights
The net income has grown by 40% year-on-year and by 39% since the previous quarter
The company's EPS rose by 39% YoY and by 38% QoQ
The company's quick ratio fell by 10% QoQ but it rose by 7% YoY
BLCO's debt is up by 5% year-on-year
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://www.bausch.com
Peers: ABT BDX ISRG SYK

Key stats

What are the main financial stats of BLCO

BLCO stock price

How has the Bausch + Lomb stock price performed over time
Intraday
3.43%
1 week
-1.35%
1 month
-5.64%
1 year
33.62%
YTD
-9.95%
QTD
-3.27%

Financial performance

How have Bausch + Lomb's revenue and profit performed over time
Revenue
$5.21B
Gross profit
$3.16B
Operating income
$229M
Net income
-$219M
Gross margin
60.6%
Net margin
-4.2%
The operating margin has surged by 193% year-on-year and by 100% since the previous quarter
Bausch + Lomb's operating income has surged by 103% QoQ
BLCO's net margin is up by 44% year-on-year and by 41% since the previous quarter
The net income has grown by 40% year-on-year and by 39% since the previous quarter

Price vs fundamentals

How does BLCO's price correlate with its fundamentals

Growth

What is Bausch + Lomb's growth rate over time

Valuation

What is Bausch + Lomb stock price valuation
P/E
N/A
P/B
0.85
P/S
1.05
EV/EBIT
47.79
EV/EBITDA
16.28
EV/Sales
1.97
The company's EPS rose by 39% YoY and by 38% QoQ
The stock's price to book (P/B) is 8% less than its 5-year quarterly average of 0.9 but 3.8% more than its last 4 quarters average of 0.8
BLCO's price to sales (P/S) is 22% lower than its 5-year quarterly average of 1.3 and 8% lower than its last 4 quarters average of 1.1
BLCO's revenue is up by 8% year-on-year and by 2.1% since the previous quarter

Efficiency

How efficient is Bausch + Lomb business performance
The return on invested capital has surged by 127% since the previous quarter
The company's return on sales has surged by 116% QoQ
The return on assets is up by 41% year-on-year and by 38% since the previous quarter
Bausch + Lomb's return on equity has increased by 39% QoQ and by 39% YoY

Dividends

What is BLCO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BLCO.

Financial health

How did Bausch + Lomb financials performed over time
Bausch + Lomb's total assets is 88% more than its total liabilities
The company's quick ratio fell by 10% QoQ but it rose by 7% YoY
The total liabilities has increased by 4.8% year-on-year but it has declined by 2.3% since the previous quarter
BLCO's debt is 21% smaller than its equity
BLCO's debt is up by 5% year-on-year
Bausch + Lomb's debt to equity has increased by 3.9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.